Vectans Pharma Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Vectans Pharma General Information
Description
Provider of pharmaceutical development and commercialization services intended to serve patients and healthcare partners. The company provides pharmaceutical development, drug optimization, technology, and marketing of medicines, thereby aiming to bring treatments to market through all phases from commercialization.
Contact Information
Website
www.vectanspharma.com(Operating Subsidiary)
Corporate Office
- 230 Bureaux de la colline
- 92213 Saint-Cloud
- France
Corporate Office
- 230 Bureaux de la colline
- 92213 Saint-Cloud
- France
Vectans Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Merger/Acquisition | 01-Jul-2025 | Completed | Generating Revenue |
Vectans Pharma Patents
Vectans Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4149426-B1 | Mucoadhesive tablet for the treatment of oropharyngeal fungal infections | Active | 12-May-2020 | ||
| EP-4149426-C0 | Mucoadhesive tablet for the treatment of oropharyngeal fungal infections | Active | 12-May-2020 | ||
| ES-3036600-T3 | Mucoadhesive tablet for the treatment of oropharyngeal fungal infections | Active | 12-May-2020 | ||
| FR-3110079-A1 | Mucoadhesive tablet for the treatment of oropharyngeal fungal infections | Pending | 12-May-2020 | ||
| EP-4149426-A1 | Mucoadhesive tablet for treating oropharyngeal fungal infections | Active | 12-May-2020 | A61K9/006 |
Vectans Pharma Investments (1)
Vectans Pharma’s most recent deal was a Corporate Asset Purchase with Onxeo (Two Non-Core Products). The deal was made on 31-Jul-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Onxeo (Two Non-Core Products) | 31-Jul-2017 | Corporate Asset Purchase | Buildings and Property |
Vectans Pharma FAQs
-
When was Vectans Pharma founded?
Vectans Pharma was founded in 2015.
-
Where is Vectans Pharma headquartered?
Vectans Pharma is headquartered in Saint-Cloud, France.
-
What industry is Vectans Pharma in?
Vectans Pharma’s primary industry is Drug Delivery.
-
Is Vectans Pharma a private or public company?
Vectans Pharma is a Private company.
-
What is Vectans Pharma’s current revenue?
The current revenue for Vectans Pharma is .
-
When was Vectans Pharma acquired?
Vectans Pharma was acquired on 01-Jul-2025.
-
Who acquired Vectans Pharma?
Vectans Pharma was acquired by Athena Pharmaceutiques and Substipharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process